Lack of confirmation of thyroid endophenotype in Bipolar Disorder Type I and their first-degree relatives

Psychoneuroendocrinology

Volumn 51, Issue , 2015, Pages 351-364

  Cobo, Jesus ^a,b   Giménez Palop, Olga ^c   Patró, Ester ^a   Pérez, Mireia ^b   Bleda, Francisco ^d   Barbero, Juan D ^a   Oliva, Joan Carles ^e   Serrano, Rosa ^c   Berlanga, Eugenio ^f   García Parés, Gemma ^a,b   Palao, Diego ^a,b  

^a Mental Health Department Corporaciò Sanitària i Universitària Parc Taulí   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c Department of Endocrinology Corporació Sanitària Parc Taulí ^*  (Spain)

^d Osona Mental Health Consorci Hospitalari de Vic   (Spain)

^e Unit of Epidemiology and Stadistic Fundació Parc Taulí Corporació Sanitària Parc Taulí   (Spain)

^f UDIAT CD   (Spain)

Author keywords

Autoimmunity; Bipolar disorders; Endophenotype; Thyroglobulin antibodies; Thyroid function; Thyroperoxidase antibodies

Indexed keywords

LITHIUM SALT; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE; AUTOANTIBODY; LIOTHYRONINE; THYROGLOBULIN;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; BIPOLAR I DISORDER; CASE CONTROL STUDY; CLINICAL ASSESSMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DRUG EFFECT; ENDOPHENOTYPE; FAMILY HISTORY; FEMALE; FIRST DEGREE RELATIVE; FREE THYROXINE INDEX; HUMAN; HYPERTHYROIDISM; IODINE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; SEX DIFFERENCE; SUBCLINICAL HYPOTHYROIDISM; THYROID DISEASE; TREATMENT OUTCOME; ADOLESCENT; AGED; BIPOLAR DISORDER; BLOOD; FAMILY; IMMUNOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; THYROID FUNCTION TEST; THYROID GLAND; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; BIPOLAR DISORDER; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; ENDOPHENOTYPES; FAMILY; FEMALE; HUMANS; MALE; MIDDLE AGED; THYROGLOBULIN; THYROID FUNCTION TESTS; THYROID GLAND; THYROXINE; TRIIODOTHYRONINE; YOUNG ADULT;

EID: 84920610839     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2014.09.032     Document Type: Article

References (52)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2002, Masson, Barcelona, (in Spanish). 4th ed., revised text.
2. Baethge C., Blumentritt H., Berghofer A., Bschor T., Glenn T., Adli M., Schlattmann P., Bauer M., Finke R. Long-term lithium treatment and thyroid antibodies: a controlled study. J. Psychiatry Neurosci. 2005, 30:423-427.
3. Bauer M., Glenn T., Pilhatsch M., Pfenning A., Whybrow P.C. Gender differences in thyroid system function: relevance to bipolar disorder and its treatment. Bipolar Disord. 2014, 16:58-71.
4. Bauer M., Goetz T., Glenn T., Whybrow P.C. The thyroid-brain interaction in thyroid disorders and mood disorders. J. Neuroendocrinol. 2008, 20:1101-1114.
5. Bauer M., Hellweg R., Gräf K.J., Baumgartner A. Treatment of refractory depression with high-dose thyroxine. Neuropsychopharmacology 1998, 18:444-455.
6. Bauer M., London E.D., Rasgon N., Berman S.M., Frye M.A., Altshuler L.L., Mandelkern M.A., Bramen J., Voytek B., Woods R., Mazziotta J.C., Whybrow P.C. Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in bipolar depression. Mol. Psychiatry 2005, 10:456-469.
7. Bauer M., London E.D., Silverman D.H., Rasgon N., Kirchheiner J., Whybrow P.C. Thyroid, brain and mood modulation in affective disorder: insights from molecular research and functional brain imaging. Pharmacopsychiatry 2003, 36(Suppl. 3):s215-s221.
8. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 1961, 4:561-571.
9. Bobes J., Bulbena A., Luque A., Dal-Ré R., Ballesteros J., Ibarra N. A comparative psychometric study of the Spanish versions with 6, 17, and 21 items of the Hamilton Depression Rating Scale. Med. Clin. (Barc.) 2003, 120:693-700. Grupo de Validacion en Español de Escalas Psicometricas, (in Spanish).
10. Brix T.H., Hansen P.S., Kyvik K.O., Hegedus L. Aggregation of thyroid autoantibodies in first-degree relatives of patients with autoimmune thyroid disease is mainly due to genes. A twin study. Clin. Endocrinol. (Oxf.) 2004, 60:329-334.
11. Brouwer J.P., Appelhof B.C., Peeters R.P., Hoogendijk W.J.G., Huyser J., Schene A.H. Thyrotropin, but not a polymorphism in type II deiodinase, predicts response to paroxetine in major depression. Eur. J. Endocrinol. 2006, 154:819-824.
12. Calabrese J.R., Shelton M.D., Bowden C.L., Rapport D.J., Suppes T., Shirley E.R., Kimmel S.E., Caban S.J. Bipolar rapid cycling: focus on depression as its hallmark. J. Clin. Psychiatry 2001, 62(Suppl. 14):s34-s41.
13. Chakrabarti S. Thyroid functions and bipolar affective disorder. J. Thyroid Res. 2011, 306-367.
14. Chang K.D., Keck P.E., Stanton S.P., McElroy S.L. Differences in thyroid function between bipolar manic and mixed states. Biol. Psychiatry 1998, 43:730-733.
15. Colom F., Vieta E., Martínez-Arán A., Garcia-Garcia M., Reinares M., Torrent C., Goikolea J.M., Banús S., Salamero M. Spanish version of a scale for the assessment of mania: validity and reliability of the Young Mania Rating Scale. Med. Clin. (Barc.) 2002, 119:366-371. (in Spanish).
16. Craddock N., Jones I. Molecular genetics of bipolar disorder. Br. J. Psychiatry 2001, 178(Suppl. 41):s128-s133.
17. Eaton W.W., Byrne M., Ewald H., Mors O., Chen C.Y., Agerbo E., Mortensen P.B. Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am. J. Psychiatry 2006, 163:521-528.
18. Fardella C., Gloger S., Figueroa R., Santis R., Gajardo C., Salgado C., Barroilhet S., Foradori A. High prevalence of thyroid abnormalities in a Chilean psychiatric outpatient population. J. Endocrinol. Invest. 2000, 23:102-106.
19. Ferracci F., Carnevale A. The neurological disorder associated with thyroid autoimmunity. J. Neurol. 2006, 253:975-984.
20. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV (SCID) Axis I Disorders 1997, American Psychiatric Press, Washington, DC.
21. Gascó-Eguiluz E., Serna-Arnaiz M.C., Vázquez-Torguet A., Peremiquel-Lluch M., Ibarz-Excuer M., Serra-i-Majem L. Prevalence of functional thyroideal disorders in the province of Lleida. Aten. Primaria 1999, 24:475-479. (in Spanish).
22. Haggerty J.J., Evans D.L., Golden R.N., Pedersen C.A., Simon J.S., Nemeroff C.B. The presence of antithyroid antibodies in patients with affective and nonaffective psychiatric disorders. Biol. Psychiatry 1990, 27:51-60.
23. Haggerty J.J., Silva S.G., Marquardt M., Mason G.A., Chang H.Y., Evans D.L., Golden R.N., Pedersen C. Prevalence of antithyroid antibodies in mood disorders. Depress. Anxiety 1997, 5:91-96.
24. Hansen P.S., Brix T.H., Iachine I., Kyvik K.O., Hegedus L. The relative importance of genetic and environmental effects for the early stages of thyroid autoimmunity: a study of healthy Danish twins. Eur. J. Endocrinol. 2006, 154:29-38.
25. Hasler G., Drevets W.C., Gould T.D., Gottesman I.I., Manji H.K. Toward constructing an endophenotype strategy for bipolar disorders. Biol. Psychiatry 2006, 60:93-105.
26. Hillegers M.H., Reichart C.G., Wals M., Verhulst F.C., Ormel J., Nolen W.A., Drexhage H.A. Signs of a higher prevalence of autoimmune thyroiditis in female offspring of bipolar parents. Eur. Neuropsychopharmacol. 2006, 17:394-399.
27. Hirschfeld R.M., Williams J.B., Spitzer R.L., Calabrese J.R., Flynn L., Keck P.E., Lewis L., McElroy S.L., Post R.M., Rapport D.J., Russell J.M., Sachs G.S., Zajecka J. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am. J. Psychiatry 2000, 157:1873-1875.
28. Hornig M., Amsterdam J.D., Kamoun M., Goodman D.B. Autoantibody disturbances in affective disorders: a function of age and gender?. J. Affect. Disord. 1999, 55:29-37.
29. Joffe R.T., Kutcher S., MacDonald C. Thyroid function and bipolar affective disorder. Psychiatry Res. 1988, 25:117-121.
30. Joffe R.T., Levitt A.J. Major depression and subclinical (grade 2) hypothyroidism. Psychoneuroendocrinology 1992, 17:215-221.
31. Kraus R.P., Phoenix E., Edmonds M.W., Nicholson I.R., Chandarana P.C., Tokmakejian S. Exaggerated TSH responses to TRH in depressed patients with normal baseline TSH. J. Clin. Psychiatry 1997, 58:266-270.
32. Kupka R.W., Nolen W.A., Post R.M., McElroy S.L., Altshuler L.L., Denicoff K.D., Frye M.A., Keck P.E., Leverich G.S., Rush A.J., Suppes T., Pollio C., Drexhage H.A. High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure. Biol. Psychiatry 2002, 51:305-311.
33. Laske C., Zank M., Klein R., Stransky E., Batra A., Buchkremer G., Schott K. Autoantibody reactivity in serum of patients with major depression, schizophrenia and healthy controls. Psychiatry Res. 2008, 158:83-86.
34. Leboyer M., Soreca I., Scott J., Frye M., Henry C., Tamouza R., Kupfer D.J. Can bipolar disorder be viewed as a multi-system inflammatory disease?. J. Affect. Disord. 2012, 141:1-10.
35. Lobo A., Perez-Echeverria M.J., Jimenez-Aznarez A., Sancho M.A. Emotional disturbances in endocrine patients. Validity of the scaled version of the General Health Questionnaire (GHQ-28). Br. J. Psychiatry 1988, 152:807-812.
36. Lucas A., Julián M.T., Cantón A., Castell C., Casamitjana R., Martínez-Cáceres E.M., Granada M.L. Undiagnosed thyroid dysfunction, thyroid antibodies, and iodine excretion in a Mediterranean population. Endocrine 2010, 38:391-396.
37. Maes M., Meltzer H.Y., Cosyns P., Suy E., Schotte C. An evaluation of basal hypothalamic-pituitary-thyroid axis function in depression: results of a large-scaled and controlled study. Psychoneuroendocrinology 1993, 18:607-620.
38. Nohr S.B., Jorgensen A., Pedersen K.M., Laurberg P. Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody-positive women living in an area with mild to moderate iodine deficiency: is iodine supplementation safe?. J. Clin. Endocrinol. Metab. 2000, 85:3191-3198.
39. Oomen H.A., Schipperijn A.J., Drexhage H.A. The prevalence of affective disorder and in particular of a rapid cycling of bipolar disorder in patients with abnormal thyroid function tests. Clin. Endocrinol. (Oxf.) 1996, 45:215-223.
40. Pedersen I.B., Knudsen N., Jorgensen T., Perrild H., Ovesen L., Laurberg P. Thyroid peroxidase and thyroglobulin autoantibodies in a large survey of populations with mild and moderate iodine deficiency. Clin. Endocrinol. (Oxf.) 2003, 258:36-42.
41. Phillips D., McLachlan S., Stephenson A., Roberts D., Moffitt S., McDonald D., Ad'hiah A., Stratton A., Young E., Klark F., Beever K., Bradbury K., Rees-Smith B. Autosomal dominant transmission of autoantibodies to thyroglobulin and thyroid peroxidase. J. Clin. Endocrinol. Metab. 1990, 70:742-746.
42. Pompili M., Gibiino S., Innamorati M., Serafini G., DelCasale A., DeRisio L., Palermo M., Montebovi F., Campi S., DeLuca V., Sher L., Tatarelli R., Biondi M., Duval F., Serretti A., Girardi P. Prolactin and thyroid hormone levels are associated with suicide attempts in psychiatric patients. Psychiatry Res. 2012, 200:389-394.
43. Pop V.J., Wijnen H.A., Lapkienne L., Bunivicius R., Vader H.L., Essed G.G. The relation between gestational thyroid parameters and depression: a reflection of the downregulation of the immune system during pregnancy?. Thyroid 2006, 16:485-492.
44. Post R.M., Kramlinger K.G., Joffe R.T., Roy-Byrne P.P., Rosoff A., Frye M.A., Huggins T. Rapid cycling bipolar affective disorder: lack of relation to hypothyroidism. Psychiatry Res. 1997, 72:1-7.
45. Seisdedos N. STAI: State-Trait Anxiety Inventory 1982, TEA, Madrid, (in Spanish).
46. Serna M.C., Serra L., Gascó E., Peremiquel M., Vila L., Ibarz M. Prevalence of anti-thyroideal antibodies in Lleida. An. Med. Interna 2000, 17:62-66. (in Spanish).
47. Surks M.I., Goswami G., Daniels G.H. The thyrotropin reference range should remain unchanged. J. Clin. Endocrinol. Metab. 2005, 90:5489-5496.
48. Surks M.I., Ortiz E., Daniels G.H., Sawin C.T., Col N.F., Cobin R.H., Franklyn J.A., Hershman J.M., Burman K.D., Denke M.A., Gorman C., Cooper R.S., Weissman N.J. Subclinical thyroid disease. Scientific review and guidelines for diagnosis and management. JAMA 2004, 291:228-238.
49. Szabolcs I., Bernard W., Horster F.A. Thyroid autoantibodies in hospitalized chronic geriatric patients: prevalence, effects of age, nonthyroidal clinical state, and thyroid function. J. Am. Geriatr. Soc. 1995, 43:670-673.
50. Thomsen A.F., Kessing L.V. Increased risk of hyperthyroidism among patients hospitalized with bipolar disorder. Bipolar Disord. 2005, 7:351-357.
51. Valle J., Ayuso-Gutierrez J.L., Abril A., Ayuso-Mateos J.L. Evaluation of thyroid function in lithium-naive bipolar patients. Eur. Psychiatry 1999, 14:341-345.
52. Vonk R., Schot A.C., Kahn R.S., Nolen W.A., Drexhage H.A. Is autoimmune thyroiditis part of the genetic vulnerability (or an endophenotype) for bipolar disorder?. Biol. Psychiatry 2007, 62:135-140.